Soy intake and metabolic health: Beyond isoflavones

Archives of Iranian Medicine

Volumn 15, Issue 8, 2012, Pages 460-461

  Azadbakht, Leila ^a,b   Esmaillzadeh, Ahmad ^a,b,c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ARGININE; C REACTIVE PROTEIN; DAIDZEIN; ESSENTIAL FATTY ACID; FIBRINOGEN; GENISTEIN; GLYCININ; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN 7S; INOSITOL; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; LYSINE; METHIONINE; PHOSPHATIDYLCHOLINE; PHYTOSTEROL; POLYPHENOL DERIVATIVE; PROTEIN TYROSINE KINASE; SAPONIN DERIVATIVE; SOYBEAN PROTEIN; TRIACYLGLYCEROL; UNSATURATED FATTY ACID; VERY LOW DENSITY LIPOPROTEIN;

CHOLESTEROL BLOOD LEVEL; DIETARY FIBER; DIETARY INTAKE; DYSLIPIDEMIA; EDITORIAL; ENZYME INHIBITION; GLUCOSE HOMEOSTASIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; LEGUME; MEDITERRANEAN DIET; METABOLIC SYNDROME X; PROTEIN BLOOD LEVEL; RISK FACTOR; SOYBEAN; WAIST CIRCUMFERENCE;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; METABOLIC SYNDROME X; SOYBEAN PROTEINS;

EID: 84864763425     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Editorial

References (27)

1. Poljicanin T, Sekerija M, Boras J, Canecki-Varzić S, Metelko Z, Kern J, et al. Metabolic syndrome-community nursing evaluation and intervention: the CroHort study. Coll Antropol. 2012; 36 (suppl 1): 35-40.
2. Jones JL, Comperatore M, Barona J, Calle MC, Andersen C, McIntosh M, et al. A Mediterranean-style, low-glycemic-load diet decreases atherogenic lipoproteins and reduces lipoprotein (a) and oxidized lowdensity lipoprotein in women with metabolic syndrome. Metabolism. 2012; 61: 366-372.
3. Azadbakht L, Surkan PJ, Esmaillzadeh A, Willett WC. The dietary approaches to stop hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients. J Nutr. 2011; 141: 1083-1088.
4. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a dietary approaches to stop hypertension eating plan on features of the metabolic syndrome. Diabetes Care. 2005; 28: 2823-2831.
5. Vieira CM, Cordeiro SN, Magdaleno Júnior R, Turato ER. The significance of dietary and behavioral changes in patients with chronic metabolic disorders: a review. Cien Saude Colet. 2011; 16: 3161-3168.
6. Lerman RH, Minich DM, Darland G, Lamb JJ, Schiltz B, Babish JG, et al. Enhancement of a modified Mediterranean-style, low glycemic load diet with specific phytochemicals improves cardiometabolic risk factors in subjects with metabolic syndrome and hypercholesterolemia in a randomized trial. Nutr Metab (Lond). 2008; 5: 29.
7. Matthan NR, Jalbert SM, Ausman LM, Kuvin JT, Karas RH, Lichtenstein AH. Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects. Am J Clin Nutr. 2007; 85: 960-966.
8. Manzoni MS, Carlos IZ, Leão da Silva P, Vendramini RC, Dâmaso AR. Effects of ferment soy product on the adipocite area reduction and dyslipidemia control in hypercholesterolemic adult male rats. Lipids Health Dis. 2008; 88: 919-924.
9. Dyrskog SE, Jeppesen PB, Colombo M, Abudula R, Hermansen K. Preventive effects of a soy-based diet supplemented with stevioside on the development of the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats. Metabolism. 2005; 54: 1181-1188.
10. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Padyab M, Hu FB, et al. Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr. 2007; 85: 735-741.
11. Bahls LD, Venturini D, Scripes Nde A, Lozovoy MA, Simão TN, Simão AN, et al. Evaluation of the intake of a low daily amount of soybeans in oxidative stress, lipid and infiammatory profile, and insulin resistance in patients with metabolic syndrome. Arq Bras Endocrinol Metabol. 2011; 55: 399-405.
12. Bakhtiary A, Yassin Z, Hanachi P, Rahmat A, Ahmad Z, Jalali F. Effects of soy on metabolic biomarkers of cardiovascular disease in elderly women with metabolic syndrome. Arch Iran Med. 2012; 15: 462-468.
13. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Hu FB, Willett WC. Soy consumption, markers of infiammation, and endothelial function: a cross-over study in postmenopausal women with the metabolic syndrome. Diabetes Care. 2007; 30: 967-973.
14. Ferreira Ede S, Silva MA, Demonte A, Neves VA. Soy β-conglycinin (7S globulin) reduces plasma and liver cholesterol in rats fed hypercholesterolemic diet. J Med Food. 2011; 14: 94-100.
15. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995; 333: 276-282.
16. Taku K, Umegaki K, Sato Y, Taki Y, Endoh K, Watanabe S. Soy isoflavones lower serum total and LDL cholesterol in humans: a metaanalysis of 11 randomized controlled trials. Am J Clin Nutr. 2007; 85: 1148-1156.
17. Cederroth CR, Nef S. Soy, phytoestrogens and metabolism: a review. Mol Cell Endocrinol. 2009; 304: 30-42.
18. Hall WL, Vafeiadou K, Hallund J, Bugel S, Reimann M, Koebnick C, et al. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr. 2006; 83: 592-600.
19. Blachier F, Lancha AH Jr, Boutry C, Tomé D. Alimentary proteins, amino acids and cholesterolemia. Amino Acids. 2010; 38: 15-22.
20. Wong WW, Smith EO, Stuff JE, Hachey DL, Heird WC, Pownell HJ. Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men. Am J Clin Nutr. 1998; 68: 1385S-1389S.
21. McVeigh BL, Dillingham BL, Lampe JW, Duncan AM. Effect of soy protein varying in isoflavone content on serum lipids in healthy young men. Am J Clin Nutr. 2006; 83: 244-251.
22. Beavers KM, Serra MC, Beavers DP, Cooke MB, Willoughby DS. Soy milk supplementation does not alter plasma markers of infiammation and oxidative stress in postmenopausal women. Nutr Res. 2009; 29: 616-622.
23. Blum A, Lang N, Peleg A, Vigder F, Israeli P, Gumanovsky M, et al. Effects of oral soy protein on markers of infiammation in postmenopausal women with mild hypercholesterolemia. Am Heart J. 2003; 145: e7.
24. Esmaillzadeh A, Azadbakht L. Legume consumption is inversely associated with serum concentrations of adhesion molecules and infiammatory biomarkers among Iranian women. J Nutr. 2012; 142: 334-339.
25. Reinwald S, Akabas SR, Weaver CM. Whole versus the piecemeal approach to evaluating soy. J Nutr. 2010; 140: 2335S-2343S.
26. Zhang W, Teng SP, Popovich DG. Generation of group B soyasaponins I and III by hydrolysis. J Agric Food Chem. 2009; 57: 3620-3625.
27. Kano M, Takayanagi T, Harada K, Sawada S, Ishikawa F. Bioavailability of isoflavones after ingestion of soy beverages in healthy adults. J Nutr. 2006; 136: 2291-2296.